Corporate Partnership Programme
The Programme is designed to form and cultivate long-term, fruitful relationships between EMBL and top-class corporate partners.
EMBL boasts some of the best scientific talent in Europe. Get in touch.
The European Molecular Biology Laboratory employs some of the greatest minds in European science. Our talent pool boasts biologists, engineers, IT professionals and countless other scientific specialisations. In addition, EMBL research has many practical and industrial applications
We harness EMBL’s entrepreneurial spirit through technology transfer programmes and technology spin-offs.
EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) is an affiliate and the commercial arm of the European Molecular Biology Laboratory (EMBL). Established in 1999, EMBLEM identifies, protects and commercialises the intellectual property developed at EMBL, by EMBL alumni and by non-EMBL third parties. EMBLEM works closely with industrial partners in the biotech, IT and engineering markets to accelerate the transfer of innovative technology from basic research to industry.
EMBLEM manages a portfolio of close to 300 individual patents, patent applications, copyrights, trademarks and utility models. The technology portfolio, which spans the life sciences, includes enabling technologies, scientific instruments, molecular tools and techniques, as well as software programmes and databases.
The Programme is designed to form and cultivate long-term, fruitful relationships between EMBL and top-class corporate partners.
A forum for interaction and knowledge exchange for those employed at the forefront of industrial bioinformatics.
A freely-available, large-scale, multi-year, public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation.
The Agri-Tech Partnership establishes collaboration with domain experts in advanced agricultural technologies from both public and private sectors.
Based in Heidelberg, Germany, EMBL Ventures invest throughout Europe to build companies that create significant commercial opportunities based on new therapeutic-treatment modalities and pharmaceuticals, next-generation enabling-technology platforms or innovations in the diagnostics and medical device area.
As an independent and focused team, EMBL Ventures moves quickly with short decision timelines.
Industry news from EMBL’s six sites
EMBL Grenoble’s new Head of Administration brings industry experience to support an environment where science can thrive
Edit
Daniel Santos-Oliván, Computational Scientist in the Torres-Sánchez group at EMBL Barcelona, talks about bringing the tools of theoretical physics to biology and how artificial intelligence is reshapi…
Edit
New ‘teaming’ projects in genomic medicine and wastewater monitoring will serve important research needs in Portugal and Latvia.
EditAbout the team/jobSafety and toxicology concerns remain one of the most persistent challenges in drug discovery. This is an exciting opportunity to join a multi-disciplinary team on a project to develop a comprehensive open source side effect resource for the scientific and pharmaceutical community,...
Closes on 12th October. Posted 14th September 2026
EditThe Dorrity group at EMBL Heidelberg is seeking a motivated and skilled molecular biologist to join as a Laboratory Officer. Our group uses cutting-edge single-cell genomic techniques to study how cells regulate gene expression over time, with the goal of understanding how individual cells make deci...
Closes on 1st October. Posted 10th September 2026
EditYour roleThe Scientific Officer contributes to the delivery of high-quality protein production services within the Protein Expression and Purification Core Facility. The role coordinates and delivers protein production projects across different expression systems and chromatogratography platforms,...
Closes on 25th September. Posted 10th September 2026
EditWith support from more than 30 countries, laboratories at six sites across Europe and thousands of scientists and engineers working together, the European Molecular Biology Laboratory (EMBL) is a powerhouse of biological expertise. EMBL is an intergovernmental organisation, headquartered in Heidelberg, and was founded in 1974 with the mission of promoting molecular biology research in Europe, training young scientists, and developing new technologies.
EMBL currently employs more than 1800 people in Barcelona, Grenoble, Hamburg, Heidelberg, EMBL-EBI Hinxton (near Cambridge), and Rome.
Publishing hundreds of research articles and hosting dozens of conferences every year, EMBL is driving visionary fundamental research and training Europe’s future scientific talent.